Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 10;9(7):85.
doi: 10.3390/cancers9070085.

The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas

Sasha Beyer  1 , Jessica Fleming  2 , Wei Meng  3 , Rajbir Singh  4 , S Jaharul Haque  5 , Arnab Chakravarti  6
Affiliations
Review

The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas

Sasha Beyer et al. Cancers (Basel). .

Abstract

MicroRNAs (miRNAs) are small, non-coding, endogenous RNA molecules that function in gene silencing by post-transcriptional regulation of gene expression. The dysregulation of miRNA plays a pivotal role in cancer tumorigenesis, including the development and progression of gliomas. Their small size, stability and ability to _target multiple oncogenes have simultaneously distinguished miRNAs as attractive candidates for biomarkers and novel therapeutic _targets for glioma patients. In this review, we summarize the most frequently cited miRNAs known to contribute to gliomagenesis and progression by regulating the defining hallmarks of gliomas, including angiogenesis, invasion, and cell metabolism. We also discuss their promising potential as prognostic and predictive biomarkers and novel therapeutic _targets, in addition to the challenges that must be overcome before their translation from bench to bedside.

Keywords: angiogenesis; cell metabolism; glioblastoma; glioma; invasion; miRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Biogenesis and regulation of microRNA (miRNA). The transcription of miRNA is regulated by epigenetic mechanisms in addition to other levels. The interplay between DNA hypermethylation and H3 lysine 9 and 20 trimethylation can form condensed and inactive chromatin structures to suppress the transcription of miRNA genes. On the other hand, DNA hypomethylation and loss of H3 lysine 9 and 20 trimethylation will reverse chromatin condensation, resulting in transcription of miRNA genes. The miRNA genes are transcribed by Polymerase II/III into a structure that folds back to form a hairpin loop. This structure is known as a primary-miRNA (pri-miRNA), which is capped and polyadenylated. The pri-miRNA is then recognized and cleaved by a nuclear protein, in complex with Dgcr8/Drosha, to form precursor miRNA (pre-miRNA) in the nucleus, which is transported into the cytoplasm by Exportin-5. The exported pre-miRNA is cleaved by RNAse III enzyme Dicer, in association with the human immunodeficiency virus transactivating response RNA-binding protein (TRBP). The product is an imperfect miRNA: miRNA duplex about 22 nucleotides in length. The duplex is unwound by helicase, after which the strand corresponding to the mature miRNA is loaded onto the RNA-induced silencing complex (RISC). Based on the _target and complementarity, mature miRNAs can bind either the 3′-untranslated region of _target mRNAs and subsequently block their translation and/or result in mRNA cleavage/degradation or, alternatively, bind to the 5′-UTR region and lead to translational activation.
Figure 2
Figure 2
Strategies for manipulation of miRNAs for therapeutic application. Endogenous miRNAs bind to specific regions in 3′-UTR of the mRNA, in order to degrade their _target. (1) Mimics are synthetic oligonucleotide duplexes that can produce a similar effect, and are used if the expression of miRNA is lost due to the malignant state. (2) Oncogenic miRNAs can be downregulated by the use of complimentary miRNAs, known as antagomirs/AMOs (Anti-miRNA oligonucleotides). AMOs (shown in green) bind to their _target miRNAs (shown in red), and prevent them from interacting with their _target mRNA, thus allowing normal translation. (3) The miRNA mask is a construct that is complementary to the mRNA sequence, intended for the binding of a particular miRNA (shown in bright green). The competitive inhibition thus prevents the miRNA binding and allows the translation of mRNA. (4) miRNA sponges (shown in blue) are transcripts expressed from strong promoters that display multiple miRNA binding sites. They can be engineered to produce a large quantity of transcripts, in order to _target a group/family of miRNAs that share a similar seed sequence.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pang C., Guan Y., Zhao K., Chen L., Bao Y., Cui R., Li G., Wang Y. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma. Int. J. Clin. Exp. Pathol. 2015;8:4943–4952. - PMC - PubMed
    1. Zheng X., Chopp M., Lu Y., Buller B., Jiang F. miR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. Cancer Lett. 2013;329:146–154. doi: 10.1016/j.canlet.2012.10.026. - DOI - PMC - PubMed
    1. Li D., Chen P., Li X.Y., Zhang L.Y., Xiong W., Zhou M., Xiao L., Zeng F., Li X.L., Wu M.H., et al. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I–III astrocytomas. OMICS. 2011;15:673–682. doi: 10.1089/omi.2011.0064. - DOI - PubMed
    1. Fowler A., Thomson D., Giles K., Maleki S., Mreich E., Wheeler H., Leedman P., Biggs M., Cook R., Little N., et al. Mir-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur. J. Cancer. 2011;47:953–963. doi: 10.1016/j.ejca.2010.11.026. - DOI - PubMed
    1. Zhou Y., Peng Y., Liu M., Jiang Y. MicroRNA-181b inhibits cellular proliferation and invasion of glioma cells via _targeting sal-like protein 4. Oncol. Res. 2016;25:947–957. doi: 10.3727/096504016X14791732531006. - DOI - PMC - PubMed
  NODES
Association 1
coding 3
HOME 2
Javascript 1
OOP 1
os 41
text 12
twitter 2
web 4